Literature DB >> 6617085

Acute pancreatitis following endoscopic retrograde cholangiopancreatography.

I Hamilton, D J Lintott, J Rothwell, A T Axon.   

Abstract

An analysis of endoscopic retrograde cholangiopancreatography (ERCP) examinations suggests that repeated contrast injection into the pancreatic duct during attempts to cannulate the bile duct is of major importance in the aetiology of acute pancreatitis after ERCP, even in the absence of pancreatic acinar opacification. The technique of ERCP can easily be modified to avoid repeated pancreatic duct injection and, by doing so, an increase in the incidence of acute pancreatitis has been reversed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6617085     DOI: 10.1016/s0009-9260(83)80156-1

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  9 in total

1.  Staging of Klatskin tumours (hilar cholangiocarcinomas): comparison of MR cholangiography, MR imaging, and endoscopic retrograde cholangiography.

Authors:  Thomas J Vogl; Wolfram O Schwarz; Matthias Heller; Christopher Herzog; Stephan Zangos; Rainer E Hintze; Peter Neuhaus; Renate M Hammerstingl
Journal:  Eur Radiol       Date:  2006-04-19       Impact factor: 5.315

2.  Towards safer endoscopic retrograde cholangiopancreatography.

Authors:  J Thornton; A Axon
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

3.  Anaphylactic reaction to aprotinin.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-15

4.  Post-ERCP pancreatitis: reduction by routine antibiotics.

Authors:  S Räty; J Sand; M Pulkkinen; M Matikainen; I Nordback
Journal:  J Gastrointest Surg       Date:  2001 Jul-Aug       Impact factor: 3.452

5.  Increased serum trypsinogen 2 and trypsin 2-alpha 1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy.

Authors:  E Kemppainen; J Hedström; P Puolakkainen; J Halttunen; V Sainio; R Haapiainen; E Kivilaakso; U H Stenman
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

6.  New endoscopic treatment for chronic pancreatitis, using contrast media containing ulinastatin and prednisolone.

Authors:  M Ohwada; N Watanabe; M Maeda; M Gotoh; J Teramoto; H Moriya; T Nakajima; T Okamoto; N Tsuji; D Kobayashi; Y Niitsu
Journal:  J Gastroenterol       Date:  1997-04       Impact factor: 7.527

7.  Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?

Authors:  K F Binmoeller; A G Harris; R Dumas; C Grimaldi; J P Delmont
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

8.  Hypotension during ERCP is common but not a risk factor for post-ERCP pancreatitis.

Authors:  B C Jacobson; D L Carr-Locke
Journal:  HPB (Oxford)       Date:  2001       Impact factor: 3.647

Review 9.  Sphincter of Oddi dysfunction and pancreatitis.

Authors:  M T McLoughlin; R M S Mitchell
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.